These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

360 related articles for article (PubMed ID: 28986561)

  • 1. Galectin-3 captures interferon-gamma in the tumor matrix reducing chemokine gradient production and T-cell tumor infiltration.
    Gordon-Alonso M; Hirsch T; Wildmann C; van der Bruggen P
    Nat Commun; 2017 Oct; 8(1):793. PubMed ID: 28986561
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intratumoral interferon-gamma increases chemokine production but fails to increase T cell infiltration of human melanoma metastases.
    Mauldin IS; Wages NA; Stowman AM; Wang E; Smolkin ME; Olson WC; Deacon DH; Smith KT; Galeassi NV; Chianese-Bullock KA; Dengel LT; Marincola FM; Petroni GR; Mullins DW; Slingluff CL
    Cancer Immunol Immunother; 2016 Oct; 65(10):1189-99. PubMed ID: 27522581
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Melanoma Induces, and Adenosine Suppresses, CXCR3-Cognate Chemokine Production and T-cell Infiltration of Lungs Bearing Metastatic-like Disease.
    Clancy-Thompson E; Perekslis TJ; Croteau W; Alexander MP; Chabanet TB; Turk MJ; Huang YH; Mullins DW
    Cancer Immunol Res; 2015 Aug; 3(8):956-67. PubMed ID: 26048575
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interferons induce CXCR3-cognate chemokine production by human metastatic melanoma.
    Dengel LT; Norrod AG; Gregory BL; Clancy-Thompson E; Burdick MD; Strieter RM; Slingluff CL; Mullins DW
    J Immunother; 2010; 33(9):965-74. PubMed ID: 20948440
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pro-inflammatory chemokine-chemokine receptor interactions within the Ewing sarcoma microenvironment determine CD8(+) T-lymphocyte infiltration and affect tumour progression.
    Berghuis D; Santos SJ; Baelde HJ; Taminiau AH; Egeler RM; Schilham MW; Hogendoorn PC; Lankester AC
    J Pathol; 2011 Feb; 223(3):347-57. PubMed ID: 21171080
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A galectin-3 ligand corrects the impaired function of human CD4 and CD8 tumor-infiltrating lymphocytes and favors tumor rejection in mice.
    Demotte N; Wieërs G; Van Der Smissen P; Moser M; Schmidt C; Thielemans K; Squifflet JL; Weynand B; Carrasco J; Lurquin C; Courtoy PJ; van der Bruggen P
    Cancer Res; 2010 Oct; 70(19):7476-88. PubMed ID: 20719885
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IDO and galectin-3 hamper the ex vivo generation of clinical grade tumor-specific T cells for adoptive cell therapy in metastatic melanoma.
    Melief SM; Visser M; van der Burg SH; Verdegaal EME
    Cancer Immunol Immunother; 2017 Jul; 66(7):913-926. PubMed ID: 28401257
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Strong expression of the lymphoattractant C-X-C chemokine Mig is associated with heavy infiltration of T cells in human malignant melanoma.
    Kunz M; Toksoy A; Goebeler M; Engelhardt E; Bröcker E; Gillitzer R
    J Pathol; 1999 Dec; 189(4):552-8. PubMed ID: 10629557
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IFNγ-induced Chemokines Are Required for CXCR3-mediated T-Cell Recruitment and Antitumor Efficacy of Anti-HER2/CD3 Bispecific Antibody.
    Li J; Ybarra R; Mak J; Herault A; De Almeida P; Arrazate A; Ziai J; Totpal K; Junttila MR; Walsh KB; Junttila TT
    Clin Cancer Res; 2018 Dec; 24(24):6447-6458. PubMed ID: 29950350
    [TBL] [Abstract][Full Text] [Related]  

  • 10. GPR182 limits antitumor immunity via chemokine scavenging in mouse melanoma models.
    Torphy RJ; Sun Y; Lin R; Caffrey-Carr A; Fujiwara Y; Ho F; Miller EN; McCarter MD; Lyons TR; Schulick RD; Kedl RM; Zhu Y
    Nat Commun; 2022 Jan; 13(1):97. PubMed ID: 35013216
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cooperation between Constitutive and Inducible Chemokines Enables T Cell Engraftment and Immune Attack in Solid Tumors.
    Dangaj D; Bruand M; Grimm AJ; Ronet C; Barras D; Duttagupta PA; Lanitis E; Duraiswamy J; Tanyi JL; Benencia F; Conejo-Garcia J; Ramay HR; Montone KT; Powell DJ; Gimotty PA; Facciabene A; Jackson DG; Weber JS; Rodig SJ; Hodi SF; Kandalaft LE; Irving M; Zhang L; Foukas P; Rusakiewicz S; Delorenzi M; Coukos G
    Cancer Cell; 2019 Jun; 35(6):885-900.e10. PubMed ID: 31185212
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Local injections of OK432 can help the infiltration of adoptively transferred CD8+ T cells into the tumor sites and synergistically induce the local production of Th1-type cytokines and CXC3 chemokines.
    Tatsugami K; Tamada K; Abe K; Harada M; Nomoto K
    Cancer Immunol Immunother; 2000 Sep; 49(7):361-8. PubMed ID: 10999462
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intratumour microbiome associated with the infiltration of cytotoxic CD8+ T cells and patient survival in cutaneous melanoma.
    Zhu G; Su H; Johnson CH; Khan SA; Kluger H; Lu L
    Eur J Cancer; 2021 Jul; 151():25-34. PubMed ID: 33962358
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CXCL10-induced migration of adoptively transferred human natural killer cells toward solid tumors causes regression of tumor growth in vivo.
    Wennerberg E; Kremer V; Childs R; Lundqvist A
    Cancer Immunol Immunother; 2015 Feb; 64(2):225-35. PubMed ID: 25344904
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CXCL9 chemokine promotes the progression of human pancreatic adenocarcinoma through STAT3-dependent cytotoxic T lymphocyte suppression.
    Gao HF; Cheng CS; Tang J; Li Y; Chen H; Meng ZQ; Chen Z; Chen LY
    Aging (Albany NY); 2020 Jan; 12(1):502-517. PubMed ID: 31913856
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SLC/CCL21-mediated anti-tumor responses require IFNgamma, MIG/CXCL9 and IP-10/CXCL10.
    Sharma S; Yang SC; Hillinger S; Zhu LX; Huang M; Batra RK; Lin JF; Burdick MD; Strieter RM; Dubinett SM
    Mol Cancer; 2003 Apr; 2():22. PubMed ID: 12740040
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epigenetic silencing of TH1-type chemokines shapes tumour immunity and immunotherapy.
    Peng D; Kryczek I; Nagarsheth N; Zhao L; Wei S; Wang W; Sun Y; Zhao E; Vatan L; Szeliga W; Kotarski J; Tarkowski R; Dou Y; Cho K; Hensley-Alford S; Munkarah A; Liu R; Zou W
    Nature; 2015 Nov; 527(7577):249-53. PubMed ID: 26503055
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased mRNA expression of chemokines in hepatocellular carcinoma with tumor-infiltrating lymphocytes.
    Hirano S; Iwashita Y; Sasaki A; Kai S; Ohta M; Kitano S
    J Gastroenterol Hepatol; 2007 May; 22(5):690-6. PubMed ID: 17444857
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Constitutive nuclear factor kappaB activity is required to elicit interferon-gamma-induced expression of chemokine CXC ligand 9 (CXCL9) and CXCL10 in human tumour cell lines.
    Hiroi M; Ohmori Y
    Biochem J; 2003 Dec; 376(Pt 2):393-402. PubMed ID: 12946268
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A short treatment with galactomannan GM-CT-01 corrects the functions of freshly isolated human tumor-infiltrating lymphocytes.
    Demotte N; Bigirimana R; Wieërs G; Stroobant V; Squifflet JL; Carrasco J; Thielemans K; Baurain JF; Van Der Smissen P; Courtoy PJ; van der Bruggen P
    Clin Cancer Res; 2014 Apr; 20(7):1823-33. PubMed ID: 24526733
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.